Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): A retrospective cohort study on longtime response predicting factors based on consensus criteria

International Journal of Surgery

Volumn 12, Issue 12, 2014, Pages 1428-1433

  Rijcken, Emile ^a   Mees, Soeren Torge ^a   Bisping, Guido ^c   Krueger, Kristin ^a   Bruewer, Matthias ^b   Senninger, Norbert ^a   Mennigen, Rudolf ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c Diabetic Department   (Germany)

Author keywords

Immune thrombocytopenia; ITP; Laparoscopic splenectomy; Long term response; Response prediction

Indexed keywords

IMMUNOGLOBULIN; STEROID;

ACCESSORY SPLEEN; ADULT; AGE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONSENSUS; CONVERSION TO OPEN SURGERY; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GENDER; HOSPITAL DISCHARGE; HUMAN; IMMUNE THROMBOCYTOPENIA; IMMUNOSUPPRESSIVE TREATMENT; LAPAROSCOPIC SPLENECTOMY; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; OPERATION DURATION; PATIENT SAFETY; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SPLEEN WEIGHT; SPLENECTOMY; SURGICAL INFECTION; SURGICAL MORTALITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT RESPONSE; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; BLOOD; LAPAROSCOPY; PROCEDURES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLEEN; STATISTICAL MODEL; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; COHORT STUDIES; CONSENSUS; FEMALE; HUMANS; LAPAROSCOPY; LINEAR MODELS; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SPLEEN; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84918799951     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2014.10.012     Document Type: Article

References (34)

1. Nugent D., McMillan R., Nichol J.L., Slichter S.J. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br. J. Haematol. 2009, 146:585-596.
2. Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D.M., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009, 113:2386-2393.
3. George J.N. Management of patients with refractory immune thrombocytopenic purpura. J.Thromb. Haemost. 2006, 4:1664-1672.
4. Cortelazzo S., Finazzi G., Buelli M., Molteni A., Viero P., Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991, 77:31-33.
5. Cohen Y.C., Djulbegovic B., Shamai-Lubovitz O., Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch. Intern Med. 2000, 160:1630-1638.
6. Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.
7. Katkhouda N., Grant S.W., Mavor E., Friedlander M.H., Lord R.V., Achanta K., et al. Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura. Surg. Endosc. 2001, 15:484-488.
8. Bresler L., Guerci A., Brunaud L., Ayav A., Sebbag H., Tortuyaux J.M., et al. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura: outcome and long-term results. World J. Surg. 2002, 26:111-114.
9. Schwartz J., Leber M.D., Gillis S., Giunta A., Eldor A., Bussel J.B. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am. J. Hematol. 2003, 72:94-98.
10. Kojouri K., Vesely S.K., Terrell D.R., George J.N. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004, 104:2623-2634.
11. Vianelli N., Galli M., de Vivo A., Intermesoli T., Giannini B., Mazzucconi M.G., et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 2005, 90:72-77.
12. Mikhael J., Northridge K., Lindquist K., Kessler C., Deuson R., Danese M. Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review. Am. J. Hematol. 2009, 84:743-748.
13. Aleem A. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients. Platelets 2011, 22:1-6.
14. Wang M., Zhang M., Zhou J., Wu Z., Zeng K., Peng B., Niu T. Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia. Int. J. Hematol. 2013, 97:610-616.
15. Qu Y., Xu J., Jiao C., Cheng Z., Ren S. Long-term outcomes of laparoscopic splenectomy versus open splenectomy for idiopathic thrombocytopenic purpura. Int. Surg. 2014, 99:286-290.
16. Montalvo J., Velazquez D., Pantoja J.P., Sierra M., López-Karpovitch X., Herrera M.F. Laparoscopic splenectomy for primary immune thrombocytopenia: clinical outcome and prognostic factors. J.Laparoendosc. Adv. Surg. Tech. A 2014, 24:466-470.
17. Delaitre B., Blezel E., Samama G., Barrat C., Gossot D., Bresler L., et al. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Surg. Laparosc. Endosc. Percutan Tech. 2002, 12:412-419.
18. Winslow E.R., Brunt L.M. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery 2003, 134:647-653.
19. Pattenden C.J., Mann C.D., Metcalfe M.S., Dyer M., Lloyd D.M. Laparoscopic splenectomy: a personal series of 140 consecutive cases. Ann. R. Coll. Surg. Engl. 2010, 92:398-402.
20. Watson D.I., Coventry B.J., Chin T., Gill P.G., Malycha P. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Surgery 1997, 121:18-22.
21. Berends F.J., Schep N., Cuesta M.A., Bonjer H.J., Kappers-Klunne M.C., Huijgens P., et al. Hematological long-term results of laparoscopic splenectomy for patients with idiopathic thrombocytopenic purpura: a case control study. Surg. Endosc. 2004, 18:766-770.
22. Delaitre B. Laparoscopic splenectomy. The "hanged spleen" technique. Surg. Endosc. 1995, 9:528-529.
23. Duperier T., Brody F., Felsher J., Walsh R.M., Rosen M., Ponsky J. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch. Surg. 2004, 139:61-66.
24. George J.N., Woolf S.H., Raskob G.E., Wasser J.S., Aledort L.M., Ballem P.J., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996, 88:3-40.
25. Stasi R., Pagano A., Stipa E., Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001, 98:952-957.
26. Cooper N., Stasi R., Cunningham-Rundles S., Feuerstein M.A., Leonard J.P., Amadori S., et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br. J. Haematol. 2004, 125:232-239.
27. Arnold D.M., Dentali F., Crowther M.A., Meyer R.M., Cook R.J., Sigouin C., et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann. Intern Med. 2007, 146:25-33.
28. Kuter D.J., Bussel J.B., Lyons R.M., Pullarkat V., Gernsheimer T.B., Senecal F.M., et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008, 371:395-403.
29. Bussel J.B., Provan D., Shamsi T., Cheng G., Psaila B., Kovaleva L., et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 373:641-648.
30. Cheng G. Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile. Ther. Adv. Hematol. 2012, 3:155-164.
31. Ojima H., Kato T., Araki K., Okamura K., Manda R., Hirayama I., et al. Factors predicting long-term responses to splenectomy in patients with idiopathic thrombocytopenic purpura. World J. Surg. 2006, 30:553-559.
32. Kwon H.C., Moon C.H., Cho Y.R., Kim M.C., Kim K.H., Han J.Y., et al. Prognostic factors of response to laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura. J.Korean Med. Sci. 2005, 20:417-420.
33. Wu J.M., Lai I.R., Yuan R.H., Yu S.C. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am. J. Surg. 2004, 187:720-723.
34. Balagué C., Vela S., Targarona E.M., Gich I.J., Muñiz E., D'Ambra A., et al. Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: study of clinical and laboratory data. Surg. Endosc. 2006, 20:1208-1213.